Norges Bank Roivant Sciences Ltd. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.36 - $11.74 $43.9 Million - $49.8 Million	4,240,777 New	4,240,777 $44.8 Million
Q4 2023 Feb 09, 2024	BUY	$8.38 - $11.58 $31 Million - $42.8 Million	3,695,967 New	3,695,967 $41.5 Million
Q3 2023 Nov 13, 2024	BUY	$9.76 - $13.19 $24.6 Million - $33.2 Million	2,520,057 New	2,520,057 $29.4 Million
Q2 2023 Aug 14, 2024	SELL	$7.09 - $10.08 $29.3 Million - $41.6 Million	-4,131,845 Reduced 97.43%	108,932 $1.1 Million

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.83B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.